| 000 | 01859 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517185551.0 | ||
| 264 | 0 | _c20171218 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1590-3729 | ||
| 024 | 7 |
_a10.1016/j.numecd.2017.10.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaschi, E | |
| 245 | 0 | 0 |
_aAdverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems. _h[electronic resource] |
| 260 |
_bNutrition, metabolism, and cardiovascular diseases : NMCD _cDec 2017 |
||
| 300 |
_a1098-1107 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aPharmacovigilance |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 _xmetabolism |
| 650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aParisotto, M | |
| 700 | 1 | _aForcesi, E | |
| 700 | 1 | _aLa Placa, M | |
| 700 | 1 | _aMarchesini, G | |
| 700 | 1 | _aDe Ponti, F | |
| 700 | 1 | _aPoluzzi, E | |
| 773 | 0 |
_tNutrition, metabolism, and cardiovascular diseases : NMCD _gvol. 27 _gno. 12 _gp. 1098-1107 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.numecd.2017.10.008 _zAvailable from publisher's website |
| 999 |
_c27823737 _d27823737 |
||